Intensive care unit management of patients with newly diagnosed acute myeloid leukemia with no organ failure

Leukemia and Lymphoma

Volumn 53, Issue 7, 2012, Pages 1352-1359

  Lengliné, Etienne ^a,b   Raffoux, Emmanuel ^a,b   Lemiale, Virginie ^a,b   Darmon, Michael ^a,b   Canet, Emmanuel ^a,b   Boissel, Nicolas ^a,b   Schlemmer, Benoît ^a,b   Dombret, Hervé ^a,b   Azoulay, Elie ^a,b  

^a SAINT LOUIS HOSPITAL   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

acute respiratory failure; Cancer; mortality; non invasive mechanical ventilation; sepsis; shock

Indexed keywords

HYPERTENSIVE FACTOR;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE RESPIRATORY FAILURE; ADULT; ARTICLE; ARTIFICIAL VENTILATION; BLOOD PRESSURE; BREATHING RATE; CANCER CHEMOTHERAPY; CONTROLLED STUDY; FEMALE; HEART RATE; HIGH RISK PATIENT; HOSPITAL ADMISSION; HUMAN; INTENSIVE CARE; INTENSIVE CARE UNIT; LENGTH OF STAY; LEUKOCYTE COUNT; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PATIENT CARE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK FACTOR; TUMOR LYSIS SYNDROME;

ADULT; BLOOD PRESSURE; FEMALE; FOLLOW-UP STUDIES; HUMANS; INTENSIVE CARE UNITS; KAPLAN-MEIER ESTIMATE; LENGTH OF STAY; LEUKEMIA, MONOCYTIC, ACUTE; LEUKEMIA, MYELOMONOCYTIC, ACUTE; LEUKEMIA, PROMYELOCYTIC, ACUTE; MALE; MIDDLE AGED; OXYGEN CONSUMPTION; RESPIRATION, ARTIFICIAL; RESPIRATORY INSUFFICIENCY; RISK FACTORS; TREATMENT OUTCOME;

EID: 84862745342     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.3109/10428194.2011.649752     Document Type: Article

References (56)

1. Darmon M, Thiery G, Ciroldi M, et al. Intensive care in patients with newly diagnosed malignancies and a need for cancer chemotherapy. Crit Care Med 2005;33:2488-2493. (Pubitemid 41682099)
2. Azoulay E, Timsit JF, Sprung CL, et al. Prevalence and factors of intensive care unit conflicts: the conflicus study. Am J Respir Crit Care Med 2009;180:853-860.
3. Azoulay E, Thiery G, Chevret S, et al. The prognosis of acuterespiratory failure in critically ill cancer patients. Medicine (Baltimore) 2004;83:360-370. (Pubitemid 39545182)
4. Darmon M, Guichard I, Vincent F, et al. Prognostic significance of acute renal injury in acute tumor lysis syndrome. Leuk Lymphoma 2010;51:221-227.
5. Mnatzaganian G, Sprung CL, Zitser-Gurevich Y, et al. Effect ofinfections on 30-day mortality among critically ill patients hospitalized in and out of the intensive care unit. Crit Care Med 2008;36:1097-1104. (Pubitemid 351482656)
6. Yoo JH, Choi SM, Lee DG, et al. Prognostic factors influencing infection-related mortality in patients with acute leukemia in Korea. J Korean Med Sci 2005;20:31-35. (Pubitemid 40342201)
7. Peigne V, Rusinova K, Karlin L, et al. Continued survival gains in recent years among critically ill myeloma patients. Intensive Care Med 2009;35:512-518.
8. Roze des Ordons AL, Chan K, Mirza I, et al. Clinical characteristicsand outcomes of patients with acute myelogenous leukemia admitted to intensive care: a case-control study. BMC Cancer 2010;10:516.
9. Schellongowski P, Staudinger T, Kundi M, et al. Prognostic factorsfor intensive care unit admission, intensive care outcome, and post-intensive care survival in patients with de novo acute myeloid leukemia: a single center experience. Haematologica 2011;96:231-237.
10. Pene F, Percheron S, Lemiale V, et al. Temporal changes in management and outcome of septic shock in patients with malignancies in the intensive care unit. Crit Care Med 2008;36:690-696.
11. Sanz MA, Jarque I, Martin G, et al. Acute promyelocytic leukemia. Therapy results and prognostic factors. Cancer 1988;61:7-13. (Pubitemid 18023103)
12. Azoulay E, Alberti C, Bornstain C, et al. Improved survival in cancer patients requiring mechanical ventilatory support: impact of noninvasive mechanical ventilatory support. Crit Care Med 2001;29:519-525. (Pubitemid 32225292)
13. Azoulay E, Mokart D, Lambert J, et al. Diagnostic strategy for hematology and oncology patients with acute respiratory failure: randomized controlled trial. Am J Respir Crit Care Med 2010;182:1038-1046.
14. Buyse S, Teixeira L, Galicier L, et al. Critical care management of patients with hemophagocytic lymphohistiocytosis. Intensive Care Med 2010;36:1695-1702.
15. Ewig S, Glasmacher A, Ulrich B, et al. Pulmonary infiltrates in neutropenic patients with acute leukemia during chemotherapy: outcome and prognostic factors. Chest 1998;114:444-451. (Pubitemid 28387521)
16. Legriel S, Marijon H, Darmon M, et al. Central neurological complications in critically ill patients with malignancies. Intensive Care Med 2010;36:232-240.
17. Perez-Zincer F, Juturi JV, Hsi ED, et al. A pulmonary syndrome in patients with acute myelomonocytic leukemia and inversion of chromosome 16. Leuk Lymphoma 2003;44:103-109. (Pubitemid 36113835)
18. Poletti V, Salvucci M, Zanchini R, et al. The lung as a target organ in patients with hematologic disorders. Haematologica 2000;85:855-864.
19. Rabe C, Mey U, Paashaus M, et al. Outcome of patients with acute myeloid leukemia and pulmonary infiltrates requiring invasive mechanical ventilation-a retrospective analysis. J Crit Care 2004;19:29-35. (Pubitemid 38525973)
20. Howard SC, Jones DP, Pui CH. The tumor lysis syndrome. N Engl J Med 2011;364:1844-1854.
21. Lahoti A, Kantarjian H, Salahudeen AK, et al. Predictors and outcome of acute kidney injury in patients with acute myelogenous leukemia or high-risk myelodysplastic syndrome. Cancer 2010;116:4063-4068.
22. Park HY, Suh GY, Jeon K, et al. Outcome and prognostic factors of patients with acute leukemia admitted to the intensive care unit for septic shock. Leuk Lymphoma 2008;49:1929-1934.
23. Park JH, Qiao B, Panageas KS, et al. Early death rate in acute promyelocytic leukemia remains high despite all-trans retinoic acid. Blood 2011;118:1248-1254.
24. Adda M, Coquet I, Darmon M, et al. Predictors of noninvasive ventilation failure in patients with hematologic malignancy and acute respiratory failure. Crit Care Med 2008;36:2766-2772.
25. Kumar A, Roberts D, Wood KE, et al. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med 2006;34:1589-1596. (Pubitemid 43810035)
26. Seymour CW, Kahn JM, Cooke CR, et al. Prediction of critical illness during out-of-hospital emergency care. JAMA 2010;304: 747-754.
27. Simchen E, Sprung CL, Galai N, et al. Survival of critically ill patients hospitalized in and out of intensive care. Crit Care Med 2007;35:449-457. (Pubitemid 46148535)
28. Thiery G, Azoulay E, Darmon M, et al. Outcome of cancer patients considered for intensive care unit admission: a hospital-wide prospective study. J Clin Oncol 2005;23:4406-4413. (Pubitemid 46207015)
29. Vardiman JW, Thiele J, Arber DA, et al. The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes. Blood 2009;114:937-951.
30. Creutzig U, Zimmermann M, Reinhardt D, et al. Early deaths and treatment-related mortality in children undergoing therapy for acute myeloid leukemia: analysis of the multicenter clinical trials AML-BFM 93 and AML-BFM 98. J Clin Oncol 2004;22:4384-4393. (Pubitemid 41185159)
31. Porcu P, Cripe LD, Ng EW, et al. Hyperleukocytic leukemias and leukostasis: a review of pathophysiology, clinical presentation and management. Leuk Lymphoma 2000;39:1-18. (Pubitemid 30662024)
32. Grimwade D, Walker H, Oliver F, et al. The importance of diagnostic cytogenetics on outcome in AML: analysis of 1,612 patients entered into the MRC AML 10 trial. The Medical Research Council Adult and Children's Leukaemia Working Parties. Blood 1998;92:2322-2333. (Pubitemid 28452973)
33. Cheson BD, Bennett JM, Kopecky KJ, et al. Revised recommendations of the International Working Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards for Therapeutic Trials in Acute Myeloid Leukemia. J Clin Oncol 2003;21:4642-4649. (Pubitemid 46594039)
34. Dohner H, Estey EH, Amadori S, et al. Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet. Blood 2010;115:453-474.
35. Larche J, Azoulay E, Fieux F, et al. Improved survival of critically ill cancer patients with septic shock. Intensive Care Med 2003;29: 1688-1695. (Pubitemid 37373811)
36. Rabbat A, Chaoui D, Montani D, et al. Prognosis of patients with acute myeloid leukaemia admitted to intensive care. Br J Haematol 2005;129:350-357. (Pubitemid 40646893)
37. Chaoui D, Legrand O, Roche N, et al. Incidence and prognostic value of respiratory events in acute leukemia. Leukemia 2004;18: 670-675. (Pubitemid 38500184)
38. Stalfelt AM, Brodin H, Pettersson S, et al. The final phase in acute myeloid leukaemia (AML): a study of cause of death, place of death and type of care during the last week of life. Leuk Res 2001;25: 673-680. (Pubitemid 32492944)
39. Juliusson G, Antunovic P, Derolf A, et al. Age and acute myeloid leukemia: real world data on decision to treat and outcomes from the Swedish Acute Leukemia Registry. Blood 2009;113:4179-4187.
40. Mengis C, Aebi S, Tobler A, et al. Assessment of differences in patient populations selected for excluded from participation in clinical phase III acute myelogenous leukemia trials. J Clin Oncol 2003;21: 3933-3939. (Pubitemid 46606206)
41. Dechartres A, Chevret S, Lambert J, et al. Inclusion of patients with acute leukemia in clinical trials: a prospective multicenter survey of 1066 cases. Ann Oncol 2011;22:224-233.
42. Dombret H, Hunault M, Faucher C, et al. Acute lysis pneumopathy after chemotherapy for acute myelomonocytic leukemia with abnormal marrow eosinophils. Cancer 1992;69:1356-1361.
43. Dutcher JP, Schiffer CA, Wiernik PH. Hyperleukocytosis in adult acute nonlymphocytic leukemia: impact on remission rate and duration, and survival. J Clin Oncol 1987;5:1364-1372.
44. Estey E, Smith TL, Keating MJ, et al. Prediction of survival during induction therapy in patients with newly diagnosed acute myeloblastic leukemia. Leukemia 1989;3:257-263. (Pubitemid 19092757)
45. Greenwood MJ, Seftel MD, Richardson C, et al. Leukocyte count as a predictor of death during remission induction in acute myeloid leukemia. Leuk Lymphoma 2006;47:1245-1252. (Pubitemid 44269630)
46. Marbello L, Ricci F, Nosari AM, et al. Outcome of hyperleukocytic adult acute myeloid leukaemia: a single-center retrospective study and review of literature. Leuk Res 2008;32:1221-1227.
47. Ventura GJ, Hester JP, Smith TL, et al. Acute myeloblastic leukemia with hyperleukocytosis: risk factors for early mortality in induction. Am J Hematol 1988;27:34-37. (Pubitemid 18052629)
48. Khassawneh BY, White P Jr, Anaissie EJ, et al. Outcome from mechanical ventilation after autologous peripheral blood stem cell transplantation. Chest 2002;121:185-188. (Pubitemid 34114245)
49. Taccone FS, Artigas AA, Sprung CL, et al. Characteristics and outcomes of cancer patients in European ICUs. Crit Care 2009;13:R15.
50. Phua J, Ngerng WJ, Lim TK. The impact of a delay in intensive care unit admission for community-acquired pneumonia. Eur Respir J 2010;36:826-833.
51. Azoulay E, Pochard F, Chevret S, et al. Compliance with triage to intensive care recommendations. Crit Care Med 2001;29:2132-2136. (Pubitemid 33063541)
52. Azoulay E, Pochard F, Kentish-Barnes N, et al. Risk of post-traumatic stress symptoms in family members of intensive care unit patients. Am J Respir Crit Care Med 2005;171:987-994. (Pubitemid 40616947)
53. Nelson JE, Meier DE, Oei EJ, et al. Self-reported symptom experience of critically ill cancer patients receiving intensive care. Crit Care Med 2001;29:277-282. (Pubitemid 32171771)
54. Lecuyer L, Chevret S, Guidet B, et al. Case volume and mortality in haematological patients with acute respiratory failure. Eur Respir J 2008;32:748-754.
55. Giles FJ, Shen Y, Kantarjian HM, et al. Leukapheresis reduces early mortality in patients with acute myeloid leukemia with high white cell counts but does not improve long-term survival. Leuk Lymphoma 2001;42:67-73. (Pubitemid 32700923)
56. Azoulay E, Recher C, Alberti C, et al. Changing use of intensive care for hematological patients: the example of multiple myeloma. Intensive Care Med 1999;25:1395-1401. (Pubitemid 30021166)